These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21660974)

  • 21. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F; Brillault J; Couet W; Olivier JC
    J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
    Roger E; Lagarce F; Garcion E; Benoit JP
    J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives.
    Kiss T; Fenyvesi F; Pasztor N; Feher P; Varadi J; Kocsan R; Szente L; Fenyvesi E; Szabo G; Vecsernyes M; Bacskay I
    Pharmazie; 2007 Jul; 62(7):557-8. PubMed ID: 17718201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal safety of water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco-2 cells.
    Tötterman AM; Schipper NG; Thompson DO; Mannermaa JP
    J Pharm Pharmacol; 1997 Jan; 49(1):43-8. PubMed ID: 9120769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of plasma binding on absorption/exsorption in the Caco-2 model of human intestinal absorption.
    Walgren RA; Walle T
    J Pharm Pharmacol; 1999 Sep; 51(9):1037-40. PubMed ID: 10528987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells.
    Roger E; Lagarce F; Garcion E; Benoit JP
    Eur J Pharm Sci; 2010 Aug; 40(5):422-9. PubMed ID: 20438839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
    Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
    Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
    Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
    Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line.
    Daruházi AE; Kiss T; Vecsernyés M; Szente L; Szőke E; Lemberkovics E
    J Pharm Biomed Anal; 2013 Oct; 84():112-6. PubMed ID: 23810850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
    Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sucrose esters increase drug penetration, but do not inhibit p-glycoprotein in caco-2 intestinal epithelial cells.
    Kiss L; Hellinger É; Pilbat AM; Kittel Á; Török Z; Füredi A; Szakács G; Veszelka S; Sipos P; Ózsvári B; Puskás LG; Vastag M; Szabó-Révész P; Deli MA
    J Pharm Sci; 2014 Oct; 103(10):3107-19. PubMed ID: 25042090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-β-cyclodextrin as an oral delivery system.
    Baek JS; So JW; Shin SC; Cho CW
    Int J Mol Med; 2012 Oct; 30(4):953-9. PubMed ID: 22859311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
    Fisher SJ; Swaan PW; Eddington ND
    J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
    Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
    Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
    Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamics of taxol in human head and neck tumors.
    Gan Y; Wientjes MG; Schuller DE; Au JL
    Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.
    Hugger ED; Audus KL; Borchardt RT
    J Pharm Sci; 2002 Sep; 91(9):1980-90. PubMed ID: 12210045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel.
    Agüeros M; Ruiz-Gatón L; Vauthier C; Bouchemal K; Espuelas S; Ponchel G; Irache JM
    Eur J Pharm Sci; 2009 Nov; 38(4):405-13. PubMed ID: 19765652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common solubilizers to estimate the Caco-2 transport of poorly water-soluble drugs.
    Takahashi Y; Kondo H; Yasuda T; Watanabe T; Kobayashi S; Yokohama S
    Int J Pharm; 2002 Oct; 246(1-2):85-94. PubMed ID: 12270611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.